Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tuulia Huhtala

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Stroke|September 17, 2017
Integrin α4 Overexpression on Rat Mesenchymal Stem Cells Enhances Transmigration and Reduces Cerebral Embolism After Intracarotid InjectionLi-Li Cui, Franziska Nitzsche, Evgeny Pryazhnikov, et al.
Molecular Cancer Therapeutics|February 5, 2014
Novel target for peptide-based imaging and treatment of brain tumorsMaija Hyvönen, Juulia Enbäck, Tuulia Huhtala, et al.
EJNMMI Radiopharmacy and Chemistry|October 30, 2019
Improved synthesis of [<sup>18</sup>F] fallypride and characterization of a Huntington's disease mouse model, zQ175DN KI, using longitudinal PET imaging of D2/D3 receptorsTuulia Huhtala, Pekka Poutiainen, Jussi Rytkönen, et al.
Molecular and Cellular Endocrinology|February 26, 2014
Preclinical pharmacology of FL442, a novel nonsteroidal androgen receptor modulatorPekka K Poutiainen, Tuulia Huhtala, Tiina Jääskeläinen, et al.
European Journal of Pharmacology|March 25, 2017
Mechanistic characterization of S 38093, a novel inverse agonist at histamine H3 receptorsAurore Sors, Fany Panayi, Lionel Bert, et al.
Progress in Neurobiology|March 22, 2020
A multimodal approach to identify clinically relevant biomarkers to comprehensively monitor disease progression in a mouse model of pediatric neurodegenerative diseaseTyler B Johnson, Jon J Brudvig, Kimmo K Lehtimäki, et al.
The Biochemical Journal|April 24, 2007
Rhizavidin from Rhizobium etli: the first natural dimer in the avidin protein familySatu H Helppolainen, Kirsi P Nurminen, Juha A E Määttä, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Stroke|September 17, 2017
Integrin α4 Overexpression on Rat Mesenchymal Stem Cells Enhances Transmigration and Reduces Cerebral Embolism After Intracarotid InjectionLi-Li Cui, Franziska Nitzsche, Evgeny Pryazhnikov, et al.
Molecular Cancer Therapeutics|February 5, 2014
Novel target for peptide-based imaging and treatment of brain tumorsMaija Hyvönen, Juulia Enbäck, Tuulia Huhtala, et al.
EJNMMI Radiopharmacy and Chemistry|October 30, 2019
Improved synthesis of [<sup>18</sup>F] fallypride and characterization of a Huntington's disease mouse model, zQ175DN KI, using longitudinal PET imaging of D2/D3 receptorsTuulia Huhtala, Pekka Poutiainen, Jussi Rytkönen, et al.
Molecular and Cellular Endocrinology|February 26, 2014
Preclinical pharmacology of FL442, a novel nonsteroidal androgen receptor modulatorPekka K Poutiainen, Tuulia Huhtala, Tiina Jääskeläinen, et al.
European Journal of Pharmacology|March 25, 2017
Mechanistic characterization of S 38093, a novel inverse agonist at histamine H3 receptorsAurore Sors, Fany Panayi, Lionel Bert, et al.
Progress in Neurobiology|March 22, 2020
A multimodal approach to identify clinically relevant biomarkers to comprehensively monitor disease progression in a mouse model of pediatric neurodegenerative diseaseTyler B Johnson, Jon J Brudvig, Kimmo K Lehtimäki, et al.
The Biochemical Journal|April 24, 2007
Rhizavidin from Rhizobium etli: the first natural dimer in the avidin protein familySatu H Helppolainen, Kirsi P Nurminen, Juha A E Määttä, et al.
Pageof 2